Jefferies2Hard to make a prediction from the disappointing lack of information from P1 and Gcn.Hoping after all this time they can list and help the gcn share price because at the moment gcn don't seem to be able to help themselves.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%